147 Participants Needed

AI Algorithm for Contact Dermatitis

MH
Overseen ByMatthew Hall
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this research is to improve how well remote patch allergy testing works and make sure they are easy and practical for people to use from home.

Research Team

MH

Matthew Hall, MD

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

Willing and able to provide informed consent

Exclusion Criteria

I have used steroids, either as a cream or pill, in the last two weeks.
I am on immunosuppressants or have a condition that weakens my immune system.
I don't have a sunburn or rash where the test will be done.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants will have two allergen patches on their forearms for 48 hours, followed by a photograph for AI and human review

1 week

Follow-up

Participants are monitored for safety and effectiveness after treatment

1 week

Treatment Details

Interventions

  • DermAI
Participant Groups
1Treatment groups
Experimental Treatment
Group I: DermAI and Patch Allergen TestingExperimental Treatment2 Interventions
Subjects will have two allergen patches on their forearms for 48 hours and a photograph image of where the patches were placed afterwards for human review and AI predictions of reactions.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security